Rallybio Corp (RLYB)
1.77
-0.09
(-4.84%)
USD |
NASDAQ |
May 17, 16:00
1.77
0.00 (0.00%)
After-Hours: 20:00
Rallybio Shareholders Equity (Quarterly): 89.16M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 89.16M |
December 31, 2023 | 106.18M |
September 30, 2023 | 123.58M |
June 30, 2023 | 139.26M |
March 31, 2023 | 155.20M |
December 31, 2022 | 169.32M |
September 30, 2022 | 131.94M |
Date | Value |
---|---|
June 30, 2022 | 147.85M |
March 31, 2022 | 163.04M |
December 31, 2021 | 175.60M |
September 30, 2021 | 186.49M |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
December 31, 2020 | 136.00M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
Mar 2021
186.49M
Maximum
Sep 2021
123.12M
Average
137.63M
Median
Shareholders Equity (Quarterly) Benchmarks
Johnson & Johnson | 70.02B |
Adial Pharmaceuticals Inc | 4.084M |
Eliem Therapeutics Inc | 106.38M |
Alpine Immune Sciences Inc | 332.70M |
Monogram Orthopaedics Inc | 10.23M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 99.36M |
Total Liabilities (Quarterly) | 10.20M |